SCHEMBL224189

SCHEMBL224189

CCC(C1CC(C)(C)N(C)C(C)(C)C1)C(Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)(OC(=O)CC(=O)O)C1CC(C)(C)N(C)C(C)(C)C1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.32
HTT P42858 2/20 0.32
PKM P14618 1/20 0.32
ALDH1A1 P00352 4/20 0.31
MAPT P10636 3/20 0.31
KMT2A Q03164 3/20 0.31
MEN1 O00255 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
TSHR P16473 2/20 0.31
MAPK1 P28482 2/20 0.31
BLM P54132 2/20 0.31
ATM Q13315 2/20 0.31
HIF1A Q16665 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
USP2 O75604 1/20 0.31
CYP2D6 P10635 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALOX15 P16050 2/20 0.30
GMNN O75496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556026 0.93
SCHEMBL28427217 0.84 KDM4E (0.35) GAAHTTPKMALDH1A1MAPT
SCHEMBL697944 0.82 GAA (0.34) GAAHTTPKMALDH1A1MAPT
SCHEMBL22260997 0.80 GAA (0.34) GAAHTTPKMALDH1A1MAPT
SCHEMBL697947 0.80 ALDH1A1 (0.33) GAAHTTPKMALDH1A1MAPT
SCHEMBL223324 0.79 ALDH1A1 (0.34) GAAHTTPKMALDH1A1MAPT
SCHEMBL224188 0.76 HMGCR (0.37) GAAHTTPKMALDH1A1MAPT
SCHEMBL8771894 0.76 GAA (0.32) GAAHTTPKMALDH1A1MAPT
SCHEMBL22260995 0.75 GAA (0.36) GAAHTTPKMALDH1A1MAPT
SCHEMBL697945 0.75 ALDH1A1 (0.35) GAAHTTPKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150203702-A1 METHOD FOR PRODUCING FLUORINATED COPOLYMER SOLUTION, AND COATING COMPOSITION ASAHI GLASS COMPANY, LIMITED (JP) 2015-07-23 US claimed
US-8563214-B2 Radiation sensitive resin composition and method of forming an interlayer insulating film SHARP CORPORATION (JP) 2013-10-22 US claimed
US-7659326-B2 Antimicrobial paint BEYOND TECHNOLOGIES AUSTRALIA PTY LTD. (AU) 2010-02-09 US claimed
US-20070161723-A1 Antimicrobial paint BEYOND TECHNOLOGIES AUSTRALIA PTY LTD (AU) 2007-07-12 US claimed
WO-2004085526-A1 PROTECTIVE COATINGS FOR MICROPOROUS SHEETS PPG INDUSTRIES OHIO INC. (US) 2004-10-07 WO claimed
US-20040191420-A1 Protective coatings for microporous sheets PPG INDUSTRIES OHIO, INC. 2004-09-30 US claimed
US-20040180211-A1 Photochromic polyurethane film of improved fatigue resistance VISION-EASE LENS, INC. 2004-09-16 US claimed
WO-2004068217-A2 PHOTOCHROMIC POLYURETHANE FILM OF IMPROVED FATIGUE RESISTANCE VISION-EASE LENS, INC. (US) 2004-08-12 WO claimed
US-6562085-B1 Against discoloration and fading; antioxidant; benzotriazole-metal complex or benzotriazole-metal salt compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-05-13 US claimed
EP-0667562-B1 Charge injection barrier for positive charging organic photoconductor HEWLETT PACKARD CO (US) 2001-03-21 EP claimed
US-5380774-A Hindered phenolic antioxidant, a pentaerythritol diphosphite, hindered amine stabilizer, a benzotriazole UV absorber HOECHST CELANESE CORPORATION (US) 1995-01-10 US claimed
EP-0430650-A1 Nylon molding compositions exhibiting improved protection against UV-light degradation HOECHST CELANESE CORPORATION (US) 1991-06-05 EP claimed
EP-4737499-A1 CURABLE EPOXY COMPOSITION FOR DYNAMO-ELECTRIC MACHINES Daicel Corporation (JP) 2026-05-06 EP disclosed
US-20260117059-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-30 US disclosed
US-20260108661-A1 Catheter TERUMO KABUSHIKI KAISHA (JP) 2026-04-23 US disclosed
US-20260109854-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-23 US disclosed
EP-0482404-A2 Organosilicon compositions containing hydrocarbon elastomers HERCULES INCORPORATED (US) 1992-04-29 EP disclosed
US-5068303-A ORGANOSILICON MATERIALS HERCULES INCORPORATED (US) 1991-11-26 US disclosed
US-5025048-A Oxygen resistant, storage-stable curable polysiloxanes hydrosilated by a polycyclic polyene and a compound containing an amine and a hydroxy, both sterically hindered HERCULES INCORPORATED (US) 1991-06-18 US disclosed
EP-0185543-A2 Thermal stabilization of acetal polymers CELANESE CORPORATION (US) 1986-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109854-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF MLLT1, CRBN, POT1 GAA 4825/4885HTT 519/4885PKM 3854/4885
US-20260117059-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE RAD51, ASH2L, H1-0 GAA 3050/4885HTT 647/4885PKM 3556/4885
US-20260108661-A1 Catheter TIPRL, PCID2, WDR82 GAA 2673/4885HTT 942/4885PKM 2951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.